Xylem Inc.XYLEarnings & Financial Report
Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.
XYL Q1 FY2026 Key Financial Metrics
Revenue
$2.1B
Gross Profit
$803.0M
Operating Profit
$244.0M
Net Profit
$189.0M
Gross Margin
37.8%
Operating Margin
11.5%
Net Margin
8.9%
YoY Growth
2.7%
EPS
$0.79
Xylem Inc. Q1 FY2026 Financial Summary
Xylem Inc. reported revenue of $2.1B (up 2.7% YoY) for Q1 FY2026, with a net profit of $189.0M (up 100.0% YoY) (8.9% margin). Cost of goods sold was $1.3B, operating expenses totaled $559.0M.
Key Financial Metrics
| Total Revenue | $2.1B |
|---|---|
| Net Profit | $189.0M |
| Gross Margin | 37.8% |
| Operating Margin | 11.5% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Xylem Inc. Q1 FY2026 revenue of $2.1B breaks down across 2 segments, led by Revenue from products at $1.8B (82.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Revenue from products | $1.8B | 82.7% |
| Revenue from services | $368.0M | 17.3% |
Xylem Inc. Annual Revenue by Year
Xylem Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $9.0B).
Xylem Inc. Quarterly Revenue & Net Profit History
Xylem Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $2.1B | +2.7% | $189.0M | 8.9% |
| Q4 FY2025 | $2.4B | +6.3% | $335.0M | 14.0% |
| Q3 FY2025 | $2.3B | +7.8% | $227.0M | 10.0% |
| Q2 FY2025 | $2.3B | +6.1% | $226.0M | 9.8% |
| Q1 FY2025 | $2.1B | +1.8% | $169.0M | 8.2% |
| Q4 FY2024 | $2.3B | +6.5% | $326.0M | 14.5% |
| Q3 FY2024 | $2.1B | +1.3% | $217.0M | 10.3% |
| Q2 FY2024 | $2.2B | +26.0% | $194.0M | 8.9% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.17B | $2.10B | $2.26B | $2.07B | $2.30B | $2.27B | $2.40B | $2.13B |
| YoY Growth | 26.0% | 1.3% | 6.5% | 1.8% | 6.1% | 7.8% | 6.3% | 2.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $15.77B | $16.05B | $16.49B | $16.56B | $17.19B | $17.30B | $17.63B | $16.95B |
| Liabilities | $5.42B | $5.45B | $5.61B | $5.50B | $5.88B | $5.85B | $5.88B | $5.72B |
| Equity | $10.34B | $10.59B | $10.64B | $10.82B | $11.07B | $11.21B | $11.48B | $10.97B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $288.0M | $311.0M | $575.0M | $33.0M | $305.0M | $360.0M | $543.0M |